Accuracy of CT Staging of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy: Cohort Evaluation within a Randomized Phase II Study

[1]  T. Yoshikawa,et al.  A Prospective Validation Study to Diagnose Serosal Invasion and Nodal Metastases of Gastric Cancer by Multidetector-row CT , 2013, Annals of Surgical Oncology.

[2]  J. Sakamoto,et al.  Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer , 2013, Cancer Chemotherapy and Pharmacology.

[3]  T. Yoshikawa,et al.  Gastrointestinal cancer: Adjuvant chemotherapy after D2 gastrectomy for gastric cancer , 2012, Nature Reviews Clinical Oncology.

[4]  Y. Ohashi,et al.  Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[6]  C. Compton,et al.  TNM seventh edition: What's new, what's changed , 2010, Cancer.

[7]  Y. Kodera,et al.  A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized Phase II trial (COMPASS). , 2010, Japanese journal of clinical oncology.

[8]  T. Kwee,et al.  Imaging in assessing lymph node status in gastric cancer , 2009, Gastric Cancer.

[9]  Yun Yen,et al.  NCCN clinical practice guidelines in oncology: hepatobiliary cancers. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[10]  I. Choi,et al.  Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer , 2008, Cancer.

[11]  Masahiro Takeuchi,et al.  S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. , 2008, The Lancet. Oncology.

[12]  Yasuo Ohashi,et al.  Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. , 2007, The New England journal of medicine.

[13]  T. Kwee,et al.  Imaging in local staging of gastric cancer: a systematic review. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Sabine Bohnacker,et al.  Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. , 2004, Radiology.

[15]  D. Cunningham,et al.  Guidelines for the management of oesophageal and gastric cancer , 2002, Gut.

[16]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[17]  S. Curley,et al.  Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  K. Kinoshita,et al.  Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients. , 1996, Hepato-gastroenterology.

[19]  C. Lightdale,et al.  Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Hodgkin Lymphoma.  NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines , 2014 .

[21]  T. Yoshikawa,et al.  Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy , 2013, Surgery Today.

[22]  J. Ajani,et al.  Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

[23]  E. Chiorean.  Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial , 2012 .

[24]  Japanese Gastric Cancer Association.  Japanese gastric cancer treatment guidelines 2010 (ver. 3) , 2011, Gastric Cancer.

[25]  M Van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.